Bonstein Sara's Form 4 filing
INSMED Inc (INSM) · filed Jul 23, 2025
- Accession no.
- 0001628280-25-035755
- Filed
- Jul 23, 2025
- Trade date
- Jul 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $6.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonstein SaraCIK 0001604019 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Common Stock | MOption exerciseAcquired | +3,443 | $26.46 | +$91,101.78 | 87,460 | Direct | |
| Jul 21, 2025 | Common Stock | MOption exerciseAcquired | +11,455 | $28.88 | +$330,820.4 | 98,915 | Direct | |
| Jul 21, 2025 | Common Stock | MOption exerciseAcquired | +15,890 | $29.13 | +$462,875.7 | 114,805 | Direct | |
| Jul 21, 2025 | Common Stock | MOption exerciseAcquired | +17,100 | $34.03 | +$581,913 | 131,905 | Direct | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −32,090 | $102.38F2 | −$3,285,374.2 | 99,815 | Direct | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −26,310 | $103.03F3 | −$2,710,719.3 | 73,505 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Common Stock | MOption exerciseDisposed | −3,443 | $0.00 | $0 | 8,580 | Direct | |
| Jul 21, 2025 | Common Stock | MOption exerciseDisposed | −11,455 | $0.00 | $0 | 0 | Direct | |
| Jul 21, 2025 | Common Stock | MOption exerciseDisposed | −15,890 | $0.00 | $0 | 47,670 | Direct | |
| Jul 21, 2025 | Common Stock | MOption exerciseDisposed | −17,100 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 32,090 shares sold at prices ranging from $101.77 to $102.76 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 26,310 shares sold at prices ranging from $102.77 to $103.37 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.